Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus.
Elizabeth CarrollHenry NeumannMaria E Aguero-RosenfeldJennifer LighterBarry M CzeislerKara MelmedAriane LewisPublished in: Epilepsia (2020)
There have been multiple descriptions of seizures during the acute infectious period in patients with COVID-19. However, there have been no reports of status epilepticus after recovery from COVID-19 infection. Herein, we discuss a patient with refractory status epilepticus 6 weeks after initial infection with COVID-19. Extensive workup demonstrated elevated inflammatory markers, recurrence of a positive nasopharyngeal SARS-CoV-2 polymerase chain reaction, and hippocampal atrophy. Postinfectious inflammation may have triggered refractory status epilepticus in a manner similar to the multisystemic inflammatory syndrome observed in children after COVID-19.